Route design before execution
We start by clarifying market priorities, product classification, evidence gaps, and timing risk.
LLINS Tech
Since 2017, LLINS Tech has supported medical device and IVD companies with regulatory strategy, dossier readiness, authorized representative services, quality systems, and clinical evidence planning across China, the EU, the US, and other target markets.
Engagement Snapshot
We start by clarifying market priorities, product classification, evidence gaps, and timing risk.
Technical documentation, testing, clinical rationale, and quality requirements are aligned as one track.
China, EU, US, and representative services are handled with continuity instead of isolated handoffs.
Core Services
Instead of splitting regulatory work into isolated tasks, LLINS Tech combines strategy, dossier support, quality systems, and representative services into a more coherent delivery flow.
Build a clearer route based on target markets, classification, evidence requirements, and business priorities.
Support MDR / IVDR readiness, CE documentation, testing plans, clinical alignment, and EU representative coordination.
Support FDA pathway assessment, 510(k) preparation, QSR alignment, and US representative service requirements.
Coordinate NMPA submission readiness, innovative product strategy, and local evidence expectations.
Connect ISO 13485, MDSAP, and QSR expectations with the documentation work needed for approvals.
Support performance studies, clinical evaluation logic, overseas testing coordination, and evidence packaging.
Delivery Model
Speed matters in regulatory programs, but speed on the wrong route creates more waste. The delivery model is designed to reduce that risk early.
Review target markets, classification, existing evidence, testing gaps, and quality system maturity.
Set priorities, key deliverables, representative needs, and realistic milestones for the program.
Link technical files, testing work, clinical evidence, and quality actions into one coordinated timeline.
Prepare for submission, post-market obligations, representative support, and future market expansion.
Operating Footprint
Public company information shows operating contacts in Shanghai and Hangzhou, together with links to representative resources in Germany, the UK, the US, and overseas testing collaboration.
Contact
A short first discussion can align the target market, device class, timing constraints, and dossier readiness.
Allan Zhang
allan.zhang@llins-tech.com +86 139 1626 5813 Room 1115, Building A, Xuhui Vanke Center, No.55 Ding'an Road, Xuhui District, ShanghaiChunquan Song
chunquan.song@llins-tech.com +86 183 5850 0842 Room 1012, Tianheng Building, 1509 Binsheng Road, Binjiang District, Hangzhou, ZhejiangStart With Clarity